Modulate Bio Inc.

ALLSTON, MA · Founded 2023 · CIK 0002026915 · Biotech · Private

GABA A positive allosteric modulator drug molecules for neurological disorders

modulatebio.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$200K
1 Form D · Jun 2024
28 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$200,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1480Arch Biopartners Inc.—$631K
1481Eyevance Pharmaceuticals——
1482PROTHERA BIOLOGICS, INC.—$250K
1483Modulate Bio Inc.—$200K
1484Aperta Biosciences, LLC—$175K
1485Treovir, Inc.—$133K
1486APTINYX, INC.—$95M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Mitchell BuckleyExecutive Officer · Promoter
  • Dario DollerDirector · Executive Officer · Promoter
  • Kevin HodgettsPromoter
  • Andrew ThomsonDirector · Executive Officer · Promoter

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.